Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gulen Ulusoy"'
Autor:
Didar Asik, Isaac Ojea-Jiménez, François Rossi, N. Dogan, Havva Yagci Acar, Ibrahim Hocaoglu, Christian Grandfils, Alper Kiraz, Gulen Ulusoy
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 133:198-207
Small hybrid nanoparticles composed of highly biocompatible Ag2S quantum dots (QD) emitting in the near-infrared region and superparamagnetic iron oxide (SPION) are produced in a simple extraction method utilizing ligand exchange mechanism. Hybrid na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51a1c5ad8f4b4c8e48b7d18336fda58f
https://doi.org/10.1016/j.colsurfb.2015.05.051
https://doi.org/10.1016/j.colsurfb.2015.05.051
Autor:
Cihan Tanrikut, Duygu Vefikuluçay Yilmaz, Gulen Ulusoy, Emel Arinç, Tugba Boyunegmez Tumer, Gürses Şahin
Publikováno v:
Leukemia Research. 34:1275-1281
It is now well established that genetic polymorphisms impairing the DNA repair capacity can disrupt the genomic integrity and potentially modulate individual's susceptibility to various cancers. In this study, we investigated the possible association
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28e026b7f9d904dc2a0da69968990460
https://doi.org/10.1016/j.leukres.2010.02.035
https://doi.org/10.1016/j.leukres.2010.02.035
Publikováno v:
Archives of Toxicology. 81:711-718
Cytochrome P4502E1 (CYP2E1) gene shows genetic polymorphisms that vary markedly in frequency among different ethnic and racial groups. We studied the genotype distributions and allele frequencies of three CYP2E1 polymorphisms: CYP2E1*5B (RsaI/PstI RF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f8c02d04f233759b55f0f1f0330aa04
https://doi.org/10.1007/s00204-007-0200-y
https://doi.org/10.1007/s00204-007-0200-y
Autor:
Gulen Ulusoy, Gürses Şahin, Emel Arinç, Tugba Boyunegmez Tumer, Sevgi Gözdaşoğlu, Orhan Adali
Publikováno v:
Oncology. 72:125-131
Background/Aims: The molecular etiology of childhood acute lymphoblastic leukemia (ALL) is likely to involve interactions between environmental factors and genetic make up. Understanding these interactions between various predisposing genes for the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbc440aea9fed9a15914e08a70d51681
https://doi.org/10.1159/000111131
https://doi.org/10.1159/000111131
Autor:
Emel Arinç, Gürses Şahin, Orhan Adali, Gulen Ulusoy, Sevgi Gözdaşoğlu, Tugba Boyunegmez Tumer
Publikováno v:
American journal of hematology. 82(10)
6-Mercaptopurine (6MP) is an essential anticancer drug used in the treatment of childhood acute lymphoblastic leukemia (ALL). Thiopurine methyltransferase (TPMT) polymorphisms are the major determinants of interindividual differences in the severe to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ac58c641c248242625744d7d806b261
https://pubmed.ncbi.nlm.nih.gov/17617792
https://pubmed.ncbi.nlm.nih.gov/17617792
Autor:
Gulen, Ulusoy, Orhan, Adali, Tugba Boyunegmez, Tumer, Gurses, Sahin, Sevgi, Gozdasoglu, Emel, Arinç
Publikováno v:
Oncology. 72(1-2)
The molecular etiology of childhood acute lymphoblastic leukemia (ALL) is likely to involve interactions between environmental factors and genetic make up. Understanding these interactions between various predisposing genes for the risk of developing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d943c6c752523b977cdd1bb3abe7a1b5
https://pubmed.ncbi.nlm.nih.gov/18025800
https://pubmed.ncbi.nlm.nih.gov/18025800
Publikováno v:
Journal of Materials Chemistry
DMSA (meso-2,3-dimercaptosuccinic acid) a prescription drug and a heavy-metal chelating agent, is shown to act both as a sulfur source and a capping agent in the aqueous synthesis of CdS quantum dots under mild conditions. Release of sulfur from DMSA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c8d2cde1b43620137272f4c79106a4f
https://doi.org/10.1039/c2jm15741a
https://doi.org/10.1039/c2jm15741a